MERIDIAN BIOSCIENCE INC 4
4 · MERIDIAN BIOSCIENCE INC · Filed Apr 1, 2016
Insider Transaction Report
Form 4
Elagin Vecheslav A
Sr VP, Research & Development
Transactions
- Award
Stock Options (Right to Buy)
2016-03-24+1,000→ 1,000 totalExercise: $19.56Exp: 2026-03-24→ Common Stock (1,000 underlying)
Holdings
- 75(indirect: By 401(k))
Common Stock
- 54,459
Common Stock
Footnotes (1)
- [F1]These options are awarded under the 2012 Stock Incentive Plan in connection with the Company's acquisition of Magellan Diagnostics, Inc. and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on March 24, 2020).